X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Piramal Healthcare with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PIRAMAL ENTERPRISES vs TEVA PHARMA (Israel) - Comparison Results

PIRAMAL ENTERPRISES    Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 PIRAMAL ENTERPRISES   TEVA PHARMA
EQUITY SHARE DATA
    PIRAMAL ENTERPRISES
Mar-16
TEVA PHARMA
Dec-13
PIRAMAL ENTERPRISES/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,0652,678-   
Low Rs8052,326-   
Sales per share (Unadj.) Rs383.01,537.0-  
Earnings per share (Unadj.) Rs55.196.0-  
Cash flow per share (Unadj.) Rs74.1220.2-  
Dividends per share (Unadj.) Rs17.5084.05-  
Dividend yield (eoy) %1.93.4 55.7%  
Book value per share (Unadj.) Rs719.91,707.3-  
Shares outstanding (eoy) m172.56848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.41.6 149.9%   
Avg P/E ratio x17.026.1 65.1%  
P/CF ratio (eoy) x12.611.4 111.1%  
Price / Book Value ratio x1.31.5 88.6%  
Dividend payout %31.887.5 36.3%   
Avg Mkt Cap Rs m161,3442,121,900 7.6%   
No. of employees `0003.844.9 8.4%   
Total wages/salary Rs m16,8980-   
Avg. sales/employee Rs Th17,472.628,998.7 60.3%   
Avg. wages/employee Rs Th4,466.90-   
Avg. net profit/employee Rs Th2,512.81,811.5 138.7%   
INCOME DATA
Net Sales Rs m66,0991,303,346 5.1%  
Other income Rs m2,4250-   
Total revenues Rs m68,5241,303,346 5.3%   
Gross profit Rs m18,723356,922 5.2%  
Depreciation Rs m3,274105,351 3.1%   
Interest Rs m9,38825,600 36.7%   
Profit before tax Rs m8,485225,972 3.8%   
Minority Interest Rs m31,027 0.3%   
Prior Period Items Rs m1,5930-   
Extraordinary Inc (Exp) Rs m457-148,338 -0.3%   
Tax Rs m1,032-2,759 -37.4%   
Profit after tax Rs m9,50681,419 11.7%  
Gross profit margin %28.327.4 103.4%  
Effective tax rate %12.2-1.2 -996.1%   
Net profit margin %14.46.2 230.2%  
BALANCE SHEET DATA
Current assets Rs m47,488880,275 5.4%   
Current liabilities Rs m104,362767,674 13.6%   
Net working cap to sales %-86.08.6 -996.0%  
Current ratio x0.51.1 39.7%  
Inventory Days Days4191 44.7%  
Debtors Days Days5196 53.3%  
Net fixed assets Rs m26,532425,702 6.2%   
Share capital Rs m3453,208 10.8%   
"Free" reserves Rs m114,0240-   
Net worth Rs m124,2211,447,770 8.6%   
Long term debt Rs m75,812666,430 11.4%   
Total assets Rs m308,3562,978,564 10.4%  
Interest coverage x1.99.8 19.4%   
Debt to equity ratio x0.60.5 132.6%  
Sales to assets ratio x0.20.4 49.0%   
Return on assets %6.13.6 170.5%  
Return on equity %7.75.6 136.1%  
Return on capital %10.04.9 202.0%  
Exports to sales %17.20-   
Imports to sales %6.60-   
Net fx Rs m9,2530-   
CASH FLOW
From Operations Rs m-67,773207,686 -32.6%  
From Investments Rs m-8,768-73,592 11.9%  
From Financial Activity Rs m76,199-249,133 -30.6%  
Net Cashflow Rs m-342-115,039 0.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 64.16 Rs / USD

Compare PIRAMAL ENTERPRISES With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare PIRAMAL ENTERPRISES With: SUN PHARMA  NOVARTIS  GSK PHARMA  STRIDES SHASUN LTD  UNICHEM LAB  



Today's Market

Global Markets Remain Volatile Ahead of US Growth Concerns(RoundUp)

Benchmark indices in US corrected marginally by 0.8% during the week. Minutes of Federal Reserve's July meeting are out and the situation looks to be in favor of the emerging markets.

Related Views On News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PIRAMAL ENTERPRISES SHARE PRICE


Aug 18, 2017 (Close)

TRACK PIRAMAL ENTERPRISES

  • Track your investment in PIRAMAL ENTERPRISES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PIRAMAL ENTERPRISES

PIRAMAL ENTERPRISES 8-QTR ANALYSIS

COMPARE PIRAMAL ENTERPRISES WITH

MARKET STATS